Related Experiment Video
Updated: Aug 29, 2025

Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound 30/45MHZ System
Published on: May 5, 2018
Multiple subtypes of coxsackievirus group B can cause congenital heart disease
Vipul Sharma1, Lisa S Goessling1, Anoop K Brar1
1Division of Pediatric Cardiothoracic Surgery, Department of Surgery, Washington University School of Medicine, St. Louis, Missouri, USA.
Insights
Prenatal coxsackievirus B (CVB) infection in mice causes congenital heart defects (CHD), with co-infections increasing severity. This study links maternal CVB exposure to fetal heart abnormalities, not limited to a single serotype.
Area of Science:
- Cardiology
- Virology
- Developmental Biology
Background:
- Coxsackievirus B (CVB) is a common cause of viral myocarditis.
- CVB targets cardiomyocytes via specific receptors present in the fetal heart.
- Maternal CVB infection during pregnancy is hypothesized to contribute to congenital heart defect (CHD) pathogenesis.
Purpose of the Study:
- To investigate the role of different coxsackievirus B serotypes in causing congenital heart defects (CHD).
- To establish a murine model for studying prenatal CVB infection and its impact on fetal heart development.
Main Methods:
- Pregnant mice were infected with CVB1, CVB4, or a combination of CVB3 + CVB4 during a critical gestational period.
- Offspring were examined for fetal death and the presence of heart defects.
Main Results:
- Maternal CVB infection led to significant rates of ventricular septal defects (VSD) and non-compaction of ventricular myocardium (NC).
- CVB1 infection resulted in 44% VSD and 41.2% NC; CVB4 resulted in 31.7% VSD and 13.3% NC.
- Co-infection with CVB3 + CVB4 showed the highest incidence of fetal pathology (51.3% VSD, 41% NC) and fetal death (46.2%). Male fetuses were more susceptible.
Conclusions:
- Prenatal CVB infections can induce congenital heart defects in a mouse model.
- Co-infections with CVB serotypes exacerbate the severity of heart defects and fetal death.
- The study confirms a link between prenatal CVB infection and CHD development, irrespective of the specific serotype.
Background:
Different serotypes of coxsackievirus B (CVB), which is the most common cause of viral myocarditis, target cardiomyocytes through Coxsackie and Adenovirus Receptor and Decay-Accelerating Factor. Both receptors are expressed in the fetal heart. We hypothesized that infection with different serotypes of CVB during early pregnancy plays a role in pathogenesis of congenital heart defect (CHD).
Methods:
In this study, we use a murine model to infect with CVB1, CVB4, and combination of CVB3 + CVB4 during a critical period in gestation. We examined offspring of pregnant mice for fetal death and heart defects following viral infection.
Result:
Fetuses from uninfected control dams showed normal heart development, while maternal CVB infection precipitates CHD: majorly ventricular septal defects (VSD) and non-compaction of ventricular myocardium (NC), with some infrequent cases of double outlet right ventricle, left ventricle wall rupture, right ventricle hypertrophy, and thickened/dysplastic semilunar valves. Infection of pregnant dams with CVB1 leads to 44% VSD and 41.2% NC cases, while with CVB4 leads to 31.7% VSD and 13.3% NC cases. Co-infection with CVB3 + CVB4 increases fetal pathology to 51.3% VSD and 41% NC cases. Infection can also result in fetal death, with higher incidences with CVB3 + CVB4 with 46.2% cases, compared to 33.3% by CVB1 and 21.7% by CVB4. Male fetuses were more susceptible to all phenotypes.
Conclusion:
Our report shows that prenatal CVB infections can lead to pathogenesis of certain heart defects in mouse model, particularly exacerbated with co-infections. This data confirms a link between prenatal CVB infection and CHD development and highlights it is not unique to just one serotype of CVB.
More Related Videos
08:28Analysis of Congenital Heart Defects in Mouse Embryos Using Qualitative and Quantitative Histological Methods
Published on: March 10, 2020
06:03Use of Viral Entry Assays and Molecular Docking Analysis for the Identification of Antiviral Candidates against Coxsackievirus A16
Published on: July 15, 2019
Related Concept Videos
Rheumatic Heart Disease I: Introduction
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Endocarditis I: Introduction
Myocarditis I: Introduction